These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28815076)

  • 21. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.
    Kranzfelder M; Schuster T; Geinitz H; Friess H; Büchler P
    Br J Surg; 2011 Jun; 98(6):768-83. PubMed ID: 21462364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy.
    Smithers BM; Cullinan M; Thomas JM; Martin I; Barbour AP; Burmeister BH; Harvey JA; Thomson DB; Walpole ET; Gotley DC
    Dis Esophagus; 2007; 20(6):471-7. PubMed ID: 17958721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stricture rate after chemoradiotherapy and radiotherapy for oesophageal squamous cell carcinoma: a 20-year experience.
    Hamer PW; Hight SC; Ward IG; Harris DL; Woodham BL; Flint RS
    ANZ J Surg; 2019 Apr; 89(4):367-371. PubMed ID: 30791194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma.
    Morgan MA; Lewis WG; Casbard A; Roberts SA; Adams R; Clark GW; Havard TJ; Crosby TD
    Br J Surg; 2009 Nov; 96(11):1300-7. PubMed ID: 19847875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
    Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
    Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy.
    Koizumi S; Jin M; Matsuhashi T; Tawaraya S; Watanabe N; Sawaguchi M; Kanazawa N; Yamada Y; Onochi K; Kimura Y; Ohba R; Kataoka J; Hatakeyma N; Mashima H; Ohnishi H
    Gastrointest Endosc; 2014 Feb; 79(2):348-53. PubMed ID: 24125510
    [No Abstract]   [Full Text] [Related]  

  • 29. [Techniques for Preventing Postoperative Complication in Esophageal Salvage Surgery].
    Iwama M; Yasuda T; Shiraishi O; Kato H; Hiraki Y; Tanaka Y; Yasuda A; Shinkai M; Imano M; Kimura Y; Imamoto H
    Kyobu Geka; 2017 Jul; 70(8):720-727. PubMed ID: 28790297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment clinical stage predicts locoregional recurrence in patients with esophageal cancer who achieved a complete clinical response to chemoradiotherapy.
    Liw PX; Wen YW; Tsai CY; Chang HK; Tseng CK; Hung TM; Chao YK
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2233-2242.e2. PubMed ID: 29397973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy.
    Machiels M; Wouterse SJ; Geijsen ED; van Os RM; Bennink RJ; van Laarhoven HW; Hulshof MC
    J Med Imaging Radiat Oncol; 2016 Aug; 60(4):520-7. PubMed ID: 27197751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
    Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
    Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of mid & proximal oesophageal squamous cell carcinoma.
    Wong I; Law S
    Best Pract Res Clin Gastroenterol; 2018; 36-37():85-90. PubMed ID: 30551861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A Case of Esophageal Cancer with Cervical Lymph Node Recurrence Six Years after Complete Response to Definitive Chemoradiotherapy].
    Fujita S; Ohki S; Hayase S; Ujiie D; Kikuchi T; Tada T; Hanayama H; Okayama H; Sakamoto W; Endo H; Saito M; Gonda K; Saze Z; Momma T; Kono K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1821-1823. PubMed ID: 30692365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage Endoscopic Argon Plasma Coagulation After Chemoradiotherapy for Inoperable Esophageal Cancer.
    Matsutani T; Nomura T; Hagiwara N; Matsuda A; Uchida E
    Surg Laparosc Endosc Percutan Tech; 2017 Oct; 27(5):384-390. PubMed ID: 28727635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer.
    Kawaguchi G; Sasamoto R; Abe E; Ohta A; Sato H; Tanaka K; Maruyama K; Kaizu M; Ayukawa F; Yamana N; Liu J; Takeuchi M; Kobayashi M; Aoyama H
    Radiat Oncol; 2015 Jan; 10():31. PubMed ID: 25636830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
    Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion.
    Yamaguchi S; Morita M; Yamamoto M; Egashira A; Kawano H; Kinjo N; Tsujita E; Minami K; Ikebe M; Ikeda Y; Kunitake N; Toh Y
    Ann Surg Oncol; 2018 Oct; 25(11):3280-3287. PubMed ID: 30051363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.
    Xi M; Xu C; Liao Z; Hofstetter WL; Blum Murphy M; Maru DM; Bhutani MS; Lee JH; Weston B; Komaki R; Lin SH
    Radiother Oncol; 2017 Aug; 124(2):318-324. PubMed ID: 28687396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.